Orally active nonpeptide CCK-A agonists.
Glaxo Wellcome Research and Development, Research Triangle Park, North Carolina 27709, USA.
E E
EE
Sugg
L
L
Birkemo
L S
LS
Gan
T K
TK
Tippin
D000284:Administration, Oral; D000818:Animals; D001682:Biological Availability; D005746:Gastric Emptying; D006801:Humans; D007408:Intestinal Absorption; D009765:Obesity / Q000188:drug therapy; D043886:Receptor, Cholecystokinin A; D011949:Receptors, Cholecystokinin / Q000819:agonists*; D013329:Structure-Activity Relationship
D043886:Receptor, Cholecystokinin A; D011949:Receptors, Cholecystokinin